Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Primary progressive multiple sclerosis developing in the context of young onset Parkinson's disease.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland.
Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish.
The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS).
Axon growth inhibition by RhoA/ROCK in the central nervous system.
Employment needs of people with multiple sclerosis: a review of current literature and application to occupational therapy practice.
Small Molecule Inhibitor of Antigen Binding and Presentation by HLA-DR2b as a Therapeutic Strategy for the Treatment of Multiple Sclerosis.
New insights in the pathophysiology and treatment of multiple sclerosis spasticity and related symptoms. Foreword.
Urodynamics in the Evaluation of the Patient with Multiple Sclerosis: When Are They Helpful and How Do We Use Them?
Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C.
Decoding diffusivity in multiple sclerosis: analysis of optic radiation lesional and non-lesional white matter.
Improved Detection of Cortical Gray Matter Involvement in Multiple Sclerosis with Quantitative Susceptibility Mapping.
Biodistribution of in vitro-derived microglia applied intranasally and intravenously to mice: effects of aging.
Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis.
[Emerging new disease--modifying therapies for multiple sclerosis].
Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice.
Prevalence of Multiple Sclerosis in Tuscany (Central Italy): A Study Based on Validated Administrative Data.
Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.
Auditory function in children with Charcot-Marie-Tooth disease.
Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis.
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
Alemtuzumab for the treatment of multiple sclerosis.
The potential of LINGO-1 as a therapeutic target for essential tremor.
Patterns of Objective and Subjective Burden of Informal Caregivers in Multiple Sclerosis.
Direct visualization of short transverse relaxation time component (ViSTa).

Pages